- Report
- October 2024
- 199 Pages
Global
From €3422EUR$3,545USD£2,840GBP
€3802EUR$3,939USD£3,156GBP
- Report
- November 2024
- 194 Pages
Global
From €4778EUR$4,950USD£3,966GBP
- Report
- January 2024
- 139 Pages
Global
From €3763EUR$3,899USD£3,124GBP
- Report
- August 2024
- 181 Pages
Global
From €2413EUR$2,500USD£2,003GBP
- Report
- October 2024
- 151 Pages
Global
From €3205EUR$3,320USD£2,660GBP
€4006EUR$4,150USD£3,325GBP
- Report
- February 2024
- 160 Pages
Global
From €4585EUR$4,750USD£3,806GBP
- Report
- February 2024
- 110 Pages
Global
From €4585EUR$4,750USD£3,806GBP
- Report
- August 2024
- 150 Pages
Global
From €3620EUR$3,750USD£3,005GBP
- Report
- September 2023
- 160 Pages
Global
From €4730EUR$4,900USD£3,926GBP
- Report
- October 2024
- 88 Pages
Global
From €3500EUR$3,884USD£3,007GBP
Binders Excipients are a type of pharmaceutical intermediate used to bind active ingredients together in a tablet or capsule form. They are typically composed of natural or synthetic polymers, starches, cellulose derivatives, and other substances. Binders are used to improve the flowability of powders, reduce dusting, and improve the stability of the drug product. They also help to control the release of active ingredients, and can be used to modify the physical properties of the drug product.
Binders Excipients are widely used in the pharmaceutical industry, and are available in a variety of forms, including granules, powders, and pastes. They are used in a variety of applications, including tablets, capsules, and other solid dosage forms.
Some companies in the Binders Excipients market include BASF, Roquette, Ashland, Colorcon, Dow, and Lubrizol. Show Less Read more